"Generex has agreed that if the Vaccine fails the
Post# of 36537
(Total Views: 379)
Posted On: 06/07/2021 12:27:41 AM
"Generex has agreed that if the Vaccine fails the clinical trial, it will compensate the Joint Entity through one of the following methods:
1. Generex will cooperate with the Joint Entity in the entire Ii-Key platform and will grant the Joint Entity an exclusive license to use the Ii-Key platform in a number of additional areas described in the Agreement for a license fee of $50,000,000 (Fifty Million USD) minus the $5,000,000 (Five Million USD) licensing fee paid upon signing the Agreement.
2. Generex will grant the Joint Entity exclusive use of its technology and related intellectual property in Excellagen (our subsidiary Olaregren’s wound management product) for a license fee of $10,000,000 (Ten Million USD) minus the $5,000,000 (Five Million USD) licensing fee paid upon sign the Agreement."
How can you offer this? Show me the trail that shows you acquired those rights.
https://www.sec.gov/Archives/edgar/data/10597...form8k.htm
1. Generex will cooperate with the Joint Entity in the entire Ii-Key platform and will grant the Joint Entity an exclusive license to use the Ii-Key platform in a number of additional areas described in the Agreement for a license fee of $50,000,000 (Fifty Million USD) minus the $5,000,000 (Five Million USD) licensing fee paid upon signing the Agreement.
2. Generex will grant the Joint Entity exclusive use of its technology and related intellectual property in Excellagen (our subsidiary Olaregren’s wound management product) for a license fee of $10,000,000 (Ten Million USD) minus the $5,000,000 (Five Million USD) licensing fee paid upon sign the Agreement."
How can you offer this? Show me the trail that shows you acquired those rights.
https://www.sec.gov/Archives/edgar/data/10597...form8k.htm
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼